News
The approval of revakinagene taroretcel (Encelto; Neurotech) addresses a significant unmet need for patients with macular telangiectasia ... ellipsoid zone loss on OCT [optical coherence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback